M. Zatz and A. Starling, Calpains and disease, N Engl J Med, vol.352, pp.2413-2436, 2005.

M. Guglieri, F. Magri, D. Angelo, M. G. Prelle, A. Morandi et al., Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients, Hum Mutat, vol.29, pp.258-66, 2008.

C. Angelini, L. Nardetto, C. Borsato, R. Padoan, M. Fanin et al., The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B)

, Neurol Res, vol.32, pp.41-47, 2010.

S. Luo, J. Xi, W. Zhu, C. Zhao, J. Lu et al., Genetic variability and clinical spectrum of Chinese patients with limb-girdle muscular dystrophy type 2A, Muscle Nerve, vol.46, pp.723-732, 2012.

I. Richard, O. Broux, V. Allamand, F. Fougerousse, N. Chiannilkulchai et al., Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A, Cell, vol.81, pp.27-40, 1995.

I. Kramerova, E. Kudryashova, G. Venkatraman, and M. J. Spencer, Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway, Hum Mol Genet, vol.14, pp.2125-2159, 2005.

S. Duguez, M. Bartoli, and I. Richard, Calpain 3: a key regulator of the sarcomere?, FEBS J, vol.273, pp.3427-3463, 2006.
URL : https://hal.archives-ouvertes.fr/hal-01610048

Y. Ono, K. Ojima, F. Torii, E. Takaya, N. Doi et al., Skeletal muscle-specific calpain is an intracellular Na + -dependent protease, J Biol Chem, vol.285, pp.22986-98, 2010.

J. Vissing, R. Barresi, N. Witting, M. Van-ghelue, L. Gammelgaard et al., A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy, Brain, vol.139, pp.2154-63, 2016.

J. M. Martinez-thompson, Z. Niu, J. A. Tracy, S. A. Moore, A. Swenson et al., Autosomal dominant calpainopathy due to heterozygous CAPN3

C. , Muscle Nerve, vol.57, pp.679-83, 2018.

B. Nallamilli, S. Chakravorty, A. Kesari, A. Tanner, A. Ankala et al., Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients, Ann Clin TranslNeurol, vol.5, pp.1574-87, 2018.

V. Straub, A. Murphy, B. Udd, A. Corrado, . Aym-e-s et al., 229th ENMC international workshop: limb girdle muscular dystrophies -nomenclature and reformed classification, vol.28, pp.702-712, 2017.

M. Krahn, V. Biancalana, M. Cerino, A. Perrin, L. Michel-calemard et al., A National French consensus on gene lists for the diagnosis of myopathies using next-generation sequencing, Eur J Hum Genet, vol.27, pp.349-52, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02434896

M. Krahn, A. Lopez-de-munain, N. Streichenberger, R. Bernard, C. Testard et al., CAPN3 mutations in patients with idiopathic eosinophilic myositis, Ann Neurol, vol.59, pp.905-916, 2006.

S. Gorokhova, M. Cerino, Y. Mathieu, S. Courrier, J. P. Desvignes et al., Comparing targeted exome and whole exome approaches for genetic diagnosis of neuromuscular disorders, Appl Transl Genom, vol.7, pp.26-31, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01610017

R. Zenagui, D. Lacourt, H. Pegeot, K. Yauy, J. Morales et al., A reliable targeted next-generation sequencing strategy for diagnosis of myopathies and muscular dystrophies, especially for the giant titin and nebulin genes, J Mol Diagn, vol.20, pp.533-582, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01800470

J. Kaplan and D. Hamroun, The 2014 version of the gene table of monogenic neuromuscular disorders (nuclear genome), Neuromuscul Disord, vol.23, pp.1081-111, 2013.

J. T. Den-dunnen, R. Dalgleish, D. R. Maglott, R. K. Hart, M. S. Greenblatt et al., HGVS recommendations for the description of sequence variants: 2016 update, Hum Mutat, vol.37, pp.564-573, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02438000

A. Milic, N. Daniele, H. Lochm?-uller, M. Mora, G. P. Comi et al., A third of LGMD2A biopsies have normal calpain 3 proteolytic activity as determined by an in vitro assay, Neuromuscul Disord, vol.17, pp.148-56, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01610045

K. Mamchaoui, C. Trollet, A. Bigot, E. Negroni, S. Chaouch et al., Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders, Skelet Muscle, vol.1, p.34, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00651121

S. Richards, N. Aziz, S. Bale, D. Bick, S. Das et al., Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, vol.17, pp.405-429, 2015.

I. Fokkema, P. Taschner, G. Schaafsma, J. Celli, and J. F. Laros, 0: the next generation in gene variant databases, den Dunnen JT LOVD, vol.2, pp.557-63, 2011.

M. J. Landrum, J. M. Lee, M. Benson, G. R. Brown, C. Chao et al., ClinVar: improving access to variant interpretations and supporting evidence, Nucleic Acids Res, vol.46, pp.1062-1069, 2018.

I. Richard, C. Roudaut, A. Saenz, R. Pogue, J. Grimbergen et al., Calpainopathy-a survey of mutations and polymorphisms, Am J Hum Genet, vol.64, pp.1524-1564, 1999.

M. Fanin, L. Fulizio, A. C. Nascimbeni, M. Spinazzi, G. Piluso et al., Molecular diagnosis in LGMD2A: mutation analysis or protein testing?, Hum Mutat, vol.24, pp.52-62, 2004.

A. S-aenz, F. Leturcq, A. M. Cobo, J. J. Poza, X. Ferrer et al., LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene, Brain, vol.128, pp.732-774, 2005.

A. C. Nascimbeni, M. Fanin, E. Tasca, and C. Angelini, Transcriptional and translational effects of intronic CAPN3 gene mutations, Hum Mutat, vol.31, pp.1658-69, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00613752

T. Schr?-oder, J. Fuchss, I. Schneider, G. Stoltenburg-didinger, and F. Hanisch, Eosinophils in hereditary and inflammatory myopathies, Acta Myol, vol.32, pp.148-53, 2013.

F. Magri, I. Colombo, D. Bo, R. Previtali, S. Brusa et al., ISPD mutations account for a small proportion of Italian Limb Girdle Muscular Dystrophy cases, BMC Neurol, vol.15, p.172, 2015.

N. Ermolova, E. Kudryashova, M. Difranco, J. Vergara, I. Kramerova et al., Pathogenity of some limb girdle muscular dystrophy mutations can result from reduced anchorage to myofibrils and altered stability of calpain 3, Hum Mol Genet, vol.20, pp.3331-3376, 2011.

T. Liewluck and B. P. Goodman, Late-onset axial myopathy and camptocormia in a calpainopathy carrier, J Clin Neuromuscul Dis, vol.13, pp.209-222, 2012.

E. Bugiardini, J. M. Morrow, S. Shah, C. L. Wood, D. S. Lynch et al., The diagnostic value of MRI pattern recognition in distal myopathies, Front Neurol, vol.9, p.456, 2018.

M. Fanin and C. Angelini, Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: the yield and the pitfalls, Muscle Nerve, vol.52, pp.163-73, 2015.

R. S. Scalco, A. R. Gardiner, R. Pitceathly, H. , D. Schapira et al., CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies, Neuromuscul Disord, vol.26, pp.504-514, 2016.

M. Cabrera-serrano, R. Ghaoui, G. Ravenscroft, R. D. Johnsen, M. R. Davis et al., Expanding the phenotype of GMPPB mutations, Brain, vol.138, pp.836-880, 2015.

A. Rubegni, A. Malandrini, C. Dosi, G. Astrea, J. Baldacci et al., Next-generation sequencing approach to hyperCKemia: a 2-year cohort study, Neurol Genet, vol.5, p.352, 2019.

Q. Ye, R. L. Campbell, and P. L. Davies, Structures of human calpain-3 protease core with and without bound inhibitor reveal mechanisms of calpain activation, J Biol Chem, vol.293, pp.4056-70, 2018.

Z. Jia, V. Petrounevitch, A. Wong, T. Moldoveanu, P. L. Davies et al., Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain, Biophys J, vol.80, pp.2590-2596, 2001.

Y. Ono, F. Torii, K. Ojima, N. Doi, K. Yoshioka et al., Suppressed disassembly of autolyzing p94/CAPN3 by N2A connectin/titin in a genetic reporter system, J Biol Chem, vol.281, pp.18519-18550, 2006.

A. S-aenz and A. Opez-de-munain, Dominant LGMD2A: alternative diagnosis or hidden digenism?, Brain, vol.140, p.7, 2017.

J. Vissing and M. Duno, Reply: dominant LGMD2A: alternative diagnosis or hidden digenism?, Brain, vol.140, p.8, 2017.